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1019-114 Assessment  of  Ar rhythmogen ic  Potent ia l  in Brugada 
Syndrome: Comparleon Between Two Conf igurat ions  of  
ST Segment Elevation 
Mitsuaki Takami, Takanori Ikeda, Ayaka Kawase, Kenta Kumagai, Tsuyoshi Sakai, Naoki 
Tezuka, Takeshi Nakee, Yoshihise Enjoji, Kaoru Sugi, Tetsu Yamaguchi, Thired 
Department of Internal Medicine Toho University Ohashi Hospital, Tokyo, Japan. 
Background: Two ST-segment configurations (i.e., coved and saddle-back shape) have 
been dascdbed in Brugada-type electrocardiograms (ECGs), but it is controversial which 
one would have stronger arrhtyhmogenic potential. On the other hand, we recently pro- 
posed that conduction disturbance per se is arrhythmogenic in Brugada syndrome. The 
aim of this study was to examine which configuration is highly associated with life-threat- 
ening arrhythmic events and suggests having a stronger conduction disturbance. 
Methods: Consecutive 46 patients (48 ±15 years, 42 men) with Brugada-type ECG, 
undergoing signal-averaged ECG (SAECG), were enrolled. Marked ST-segment eleva- 
tion (>0.1 mV) of either the coved (n=25: group A) or saddle-beck type (n=21: group B) in 
the right chest leads was seen in all patients. No patients had structural heart disease. 
The incidence of history of life-threatening events defined as syncope and aborted sud- 
den death and the value of SAECG were compared between two groups. In this study, 
late potentials (LP) were considered as positive when two criteria (RMS40 <20 IIV and 
LAS40 >38 ms) were met. 
Results: Life-threatening events: A total of 24 patients had a history of life-threatening 
events. The incidence of life-threstening events was 17 patients (68%) in group A and 7 
patients (33%) in group B (P=0.02). SAECG: Although f-QRS duration did not differ 
between two groups (117.0¢12.5 ms vs. 111.0±10.2 ms), RMS40 and LAS40 of group A 
were significantly lower and longer, respectively than those of group B (RMS40:13.4±6.8 
I~V vs. 27.7=12.0 pV; P<0.C001, and LAS40:45.7±9.7 ms vs. 30.9±7.0 ms; P<0.0001). 
The determination of LP in group A was significantly greater than that in group B (22 
patients (88%) vs. 4 patients (19%); P<0.0001). 
Conclusion: Life-thraatening events were highly observed in patients with coved type 
ST-segment elevation. Moreover these patients have stronger conduction disturbances 
compared to patients with saddle-back type ST-segment elevation. When assessing risk 
for sudden death in patients with Brugada-type ECG, the configuration of ST-segment 
elevation should be taken into consideration. 
1019-115 Left Atrial Dimension Is Associated With Atrial 
F ibr i l la t ion Recurrence: Four-Year Echo Follow-Up Data 
RaUka Seth, Martin S. Green, Chades R. Kerr, Stuart J. Connolly, George J. Klein, 
Robert S. Sheldon, Marie Talajic, Xiaohua Wang, Paul Dorian, Karin Humphries, 
University of Ottawa Heart Institute, Ottawa, Ontario, Canada. 
The Canadian Registry of Atrial Fibrillation (CARAF) enrolled subjects with atrial fibrilla- 
tion (AF) at the first ECG-confirmed diagnosis. We have previously found a relationship 
between LA dimension (LA dim) and recurrence of AF at 2 years. 899 patients with newly 
diagnosed non-surgical AF were enrolled beginning in 1990 from 6 Canadian centers. 
Baseline and 4 year (Y4) echocardiographic data were available on 403 patients. Partici- 
pants were followed at 3 months, and then annually for AF status. Patients were classi- 
fied at 4 years as: no recurrent AF (No AF, n=137) or recurrent AF (RAF, n=266) based 
on clinical symptoms or ECG documentation. The RAF patients were subdivided into 
paroxysmal AF (PAF, n=123), chronic AF (CAF, n=140) and other (n=3). 
The mean age was 63+/-12 years, 37% were women, history of M115%, mitral valve dis- 
ease 12%, hypertension 39%, diabetes 7%, CHF 14%, left ventricular fractional shorten- 
ing 36%+/-10%. For the 403 patients, the mean LA dim was 39.92+/-7.89 mm at 
baseline, and increased to 41.18+/-8.60 mm at 4 years. Compared to the No AF group, 
the RAF group had a larger LA dim at baseline (p<0.001) and a trend toward a larger 
increase in LA dim over 4 years (p=0.053). Those who had developed CAF by 4 years 
had a larger LA dim at baseline and a larger increase in LA dim over 4 years when com- 
pared to PAF (p<0.001). See Table. 
Conclusions: Larger baseline LA dim is associated with AF recurrence. Patients who 
progressed to CAF had the largest baseline LA dim and the greatest increase in LA size 
over 4 years. 
Mean LA dim (ram) in AF groups 
AF group Baseline (SD) Year 4 (SD) 
All N=403 39.92 (7.89) 41.18 (8.60)* 
NoAF N=137 37,59 (7.41) 37.96 (7.91) 
RAF N=266 41.12 (7.87) 42.84 (8.49)* 
PAF N=123 39.06 (7.35) 39.00 (7.50) 
CAF N=140 43.13 (7.73) 46.30 (7.78)* 
*p<0.0Ol 
1019-116 Ef fects  o f  C lass  III Drugs on Prophylaxis of  Atr ia l  
F ibr i l la t ion Af ter  Card ivere ion  in High Risk Patients for 
Recurrence Predicted by P Wave Signal-Averaged ECG 
Koichi Mizumaki. Akira Fujiki, Hidehiko Nagasawa, Masao Sakabe, Kunihiro Nishida, 
Masafaka Sugao, Hiroshi Inoue, The 2rid Department of Internal Medicine, Toyama 
Medical and Pharmaceutical University, Toyama, Japan. 
Though P wave signal-averaged ECG (P-SAE) may predict recurrence of atrial fibrillation 
(AF) after cardioversion (CV), prophylactic therapy in high risk patients (pts) for AF recur- 
rence remains to be established. So, this study aimed to evaluate prophylactic effects of 
class III antiarrhythmic drugs in high risk pts for AF recurrence after CV predicted by P- 
SAE. Methods: P-SAE was recorded within 24 hours after successful CV of chronic or 
paroxysmal AI~ Abnormal P-SAE was defined as the filtered P wave duration(FPD)>137 
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msec and roof-mean-square voltage for the last 20 ms(LP20)<2.61W, which had a sensi- 
tivity of 89% and a specificity of 65% for the prediction of AF recurrence after CV 
obtained from 40 pts. Another 30 pts with abnormal P-SAE were treated with class I 
drugs (group I, n=17) or class III (amiodarone:7,dl-sofalol:6) drugs (group III, n=13) after 
CV of AF and we prospectively evaluated recurrence of AF during 6 months. Results: 
Class I drugs elongated FPD (151_+ 23 vs 166±19 msec, p<0.05) and decreased LP20 
(2.3_+ 0.4 vs 1.9±0.5pV, p<0.O5). However, class Ill drugs did not alter significantly both 
FPD(171_+ 32 vs 176±34 msec) and LP2O (1.7+_ 0.7 vs 1.9-+0.6pV). The recurrence rate 
of AF was significantly lower (p<0.05) in group Ill (5/13,38%) than in group I (13/17,76%). 
Conclusione: In high risk pts for AF recurrence after CV predicted by P-SAE, class Ill 
drugs did not worsen P-SAE variables, whereas class I drugs did. Thus, class III drugs 
were more effective than class I drugs to prevent AF recurrence in these pts. 
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1019-117 Exerc i se  is Super io r  to  Pacing for T Wave Alternans 
Measurement 
Eric J. Rashba, Ahmed Osman, Karen MacMurdy, Samantha Sarang, Stephen R. 
Shorofsky, Michael R. Gold, University of Maryland, Baltimore, Maryland. 
Background: T wave altemans (TWA) is a heart rste-dapecdent measure of vulnerabil- 
ity to ventdcular arrbythmias. Atrial pacing and exercise are both used as provocative 
stimuli to elicit TWA. However, the prognostic value of these two testing methods has not 
been compared. 
Methods: This was a prospective study of 251 patients with coronary artery disease and 
EF _< 40% who were referred for electrophysiologic studies. TWA testing was performed 
with atrial pacing (n=178) or exercise (n=f43) in the absence of anti-arrhythmic drugs or 
beta-blockers; 70 of these patients had testing with both sodalities. The endpoint was 
the combined incidence of sustained ventricular arrhythmia, appropriate defibrillator ther- 
apy or death. 
Results: The cohort had a mean age of 65+10 years, mean ejection fraction of 27_+8 % 
and 89% had symptomatic heart failure. The mean duration of follow-up was 499~395 
days. There were no significant differences in baseline characteristics or treatment 
between the atrial pacing and exercise groups. Cox survivat analysis in subjects with 
determinate results revealed that exercise TWA was an independent predictor of arrhyth- 
sic events (HR 2.5, 95% CI 1.2 - 5.3, p = 0.02). In contrast, pacing TWA did not predict 
outcome events (HR=1.1,95% CI 0.6 - 1.9, p = 0.8). in the subgroup that had both tests 
performed, pacing TWA yielded more positive tests (73% vs 47%) and fewer indetermi- 
nate results (7% vs 27%, p = 0.02); the concordance between pacing and exercise TWA 
results was only 56%. 
Conclusion: Exercise TWA is useful for risk stratification of patients with ischemic cardi- 
omyopathy. Pacing TWA does not have prognostic value in this population. 
1019-118 Abnormal QT Prolongation and Peychotroplc Drug 
Therapy in Psychiatric Patients: S ign i f i cance  o f  
Bradycardia-Dependent QT Prolongation 
Tsuneaki Sadanaga. Fumiko Sadanaga, Hiroshi Yao, Kyushu Universi~ Fukuoka, 
Japan. 
Background: Sudden unexplained death in psychiatric patients might be associated with 
drug-induced arrhythmias. Since many psychotropic drugs have electrophysiological prop- 
erties similar to class I antiarrhythmic drugs, they might lengthen QT interval and cause tor- 
sabes de pointes, Methods: Electrocardiograms (ECG) were obtained in 409 psychiatric 
patients (229 men, 180 women) receiving psychotropic drugs at the Hizen National Hospi- 
tal. QTc was calculated by the Bazett's formula. In order to elucidate the heart rate depen- 
dence of QT prolongation, QT intervals and the preceding R-R intervals (50-100 beats) 
were measured at various heart rates (50-100/min) by 24-hour Holter ECG (CM5 lead) in 
77 patients. We estimated the QT intervals at the heart rates of 80 and 50/min (QT80, 
QT50) by the regression curve (square root of preceding R-R intervals vs. QT intervals). 
Results: Mean QTc interval (longest in 12 ECG leads) was prolonged to 444=32 ms (men, 
437±32, women, 453:~.9 ms, mean heart rate 82±15/min). QTc interval >460 ms was 
observed in 92 (22%) patients (16% in men and 31% in women). QTc interval >500 ms was 
observed in 19 (5%) patients (3% in men and 7% in women). Mean QT80 and QT5O were 
385±27 and 466±42 ms, which were significantly longer than those in healthy reference 
group (QT80 and QT50, 370±15 and 440±20 ms, n=65). QT80 > 400 ms (mean+2SD of 
the reference group) was observed in 16 (21%) patients. In the remaining 61 patients in 
whom QT80 < 400ms, bradycardia-dependent QT prolongation was prominent and QT50 
exceeded 480 ms (meen+2SD) in 12 patients, Accordingly, QT50 > 480 ms was observed 
in 28 (36%) patients. Therefore, we need to pay additional attention to the bradycardia- 
dependent QT prolongation even when the QT interval was not prolonged at usual heart 
rates (around 80/min). Since torsedes de pointas is prone to occur at slower heart rates, 
